ENDS Cardiovascular System: Difference between revisions
adding content |
No edit summary |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
[[File:Heart noun 4451 cc.svg|alt=Heart icon |thumb|Heart icon]] | |||
<translate> | <translate> | ||
<!--T:1--> | <!--T:1--> | ||
| Line 28: | Line 30: | ||
*Citation: Haptonstall KP, Choroomi Y, Moheimani R, Nguyen K, Tran E, Lakhani K, Ruedisueli I, Gornbein J, Middlekauff HR. Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people. Am J Physiol Heart Circ Physiol. 2020 Sep 1;319(3):H547-H556. doi: 10.1152/ajpheart.00307.2020. Epub 2020 Jul 31. PMID: 32734819; PMCID: PMC7509270. | *Citation: Haptonstall KP, Choroomi Y, Moheimani R, Nguyen K, Tran E, Lakhani K, Ruedisueli I, Gornbein J, Middlekauff HR. Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people. Am J Physiol Heart Circ Physiol. 2020 Sep 1;319(3):H547-H556. doi: 10.1152/ajpheart.00307.2020. Epub 2020 Jul 31. PMID: 32734819; PMCID: PMC7509270. | ||
===2019: Global Forum on Nicotine (GFN) The effect of electronic nicotine delivery systems (ends) and new tobacco products on the risk of cardiovascular disease in people with high tobacco dependence=== <!--T:7--> | ===2019: [https://gfn.events/documents/133/gfn_2018_reader.pdf Global Forum on Nicotine (GFN) The effect of electronic nicotine delivery systems (ends) and new tobacco products on the risk of cardiovascular disease in people with high tobacco dependence]=== <!--T:7--> | ||
| Line 42: | Line 44: | ||
that debunks this study: Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health | that debunks this study: [https://onlinelibrary.wiley.com/doi/10.1111/add.15067 Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health] | ||
===2019: Is E-Cigarette Use associated with coronary heart disease and myocardial infarction?=== <!--T:11--> | ===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767743/ 2019: Is E-Cigarette Use associated with coronary heart disease and myocardial infarction?]=== <!--T:11--> | ||
| Line 58: | Line 61: | ||
===2019: (November 15) Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes=== <!--T:13--> | ===[https://pubmed.ncbi.nlm.nih.gov/31740017/ 2019: (November 15) Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes]=== <!--T:13--> | ||
| Line 64: | Line 67: | ||
(Jacob George, MD, Muhammad Hussain, MSc, Thenmalar Vadiveloo, PhD, Sheila Ireland, BSc, Pippa Hopkinson, BSc, Allan D.Struthers, MD, Peter T. Donnan, PhD, Faisel Khan, PhD, Chim C.Lang, MD | (Jacob George, MD, Muhammad Hussain, MSc, Thenmalar Vadiveloo, PhD, Sheila Ireland, BSc, Pippa Hopkinson, BSc, Allan D.Struthers, MD, Peter T. Donnan, PhD, Faisel Khan, PhD, Chim C.Lang, MD | ||
E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers is unknown. Meta-analysis of flow-mediated dilation (FMD) studies indicate 13% lower pooled, adjusted relative risks of cardiovascular events with every 1% improvement in FMD. | E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers is unknown. Meta-analysis of flow-mediated dilation (FMD) studies indicate 13% lower pooled, adjusted relative risks of cardiovascular events with every 1% improvement in FMD. | ||
*See additional comments: [https://www.sciencemediacentre.org/expert-reaction-to-the-vesuvius-study-comparing-the-cardiovascular-effects-of-smoking-and-vaping/ Science Media Centre] | |||
===2019: Electronic cigarettes and cardiovascular health: what do we know so far?=== <!--T:15--> | ===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592370/ 2019: Electronic cigarettes and cardiovascular health: what do we know so far?]=== <!--T:15--> | ||
<!--T:16--> | <!--T:16--> | ||
| Line 76: | Line 77: | ||
===2017: Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation (G2) and third-generation (G3) electronic cigarette users=== <!--T:17--> | ===[https://pubmed.ncbi.nlm.nih.gov/27729564/ 2017: Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation (G2) and third-generation (G3) electronic cigarette users]=== <!--T:17--> | ||
<!--T:18--> | <!--T:18--> | ||
| Line 84: | Line 85: | ||
===2017: Electronic cigarette smoking increases of arterial stiffness and oxidative stress to a lesser extent than a single normal cigarette: an acute and chronic study=== <!--T:19--> | ===[https://pubmed.ncbi.nlm.nih.gov/29335291/ 2017: Electronic cigarette smoking increases of arterial stiffness and oxidative stress to a lesser extent than a single normal cigarette: an acute and chronic study]=== <!--T:19--> | ||
<!--T:20--> | <!--T:20--> | ||
| Line 92: | Line 93: | ||
===2016: Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture=== <!--T:21--> | ===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907307/ 2016: Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture]=== <!--T:21--> | ||
<!--T:22--> | <!--T:22--> | ||
| Line 102: | Line 103: | ||
===2013: Chronic Idiopathic Neutrophilia in A Smoker, Relieved after Smoking Cessation with the Use of Electronic Cigarette: a Case Report=== <!--T:23--> | ===[https://pubmed.ncbi.nlm.nih.gov/23439796/ 2013: Chronic Idiopathic Neutrophilia in A Smoker, Relieved after Smoking Cessation with the Use of Electronic Cigarette: a Case Report]=== <!--T:23--> | ||
<!--T:24--> | <!--T:24--> | ||
| Line 111: | Line 112: | ||
===2012: Acute effects of electronic and tobacco cigarette smoking on complete blood count=== <!--T:25--> | ===[https://pubmed.ncbi.nlm.nih.gov/22858449/ 2012: Acute effects of electronic and tobacco cigarette smoking on complete blood count]=== <!--T:25--> | ||
<!--T:26--> | <!--T:26--> | ||
| Line 120: | Line 121: | ||
===2010: A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects=== <!--T:27--> | ===[https://pubmed.ncbi.nlm.nih.gov/20647410/ 2010: A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects]=== <!--T:27--> | ||
| Line 161: | Line 162: | ||
===2017: Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine Constituents=== <!--T:35--> | ===2017: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634299/#:~:text=In%20conclusion%2C%20the%20acute%20sympathomimetic,constituents%20in%20e%E2%80%90cigarette%20aerosol. Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine Constituents]=== <!--T:35--> | ||
<!--T:36--> | <!--T:36--> | ||
| Line 170: | Line 171: | ||
===2016: Cardiovascular toxicity of nicotine: Implications for electronic cigarette use=== <!--T:37--> | ===2016: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958544/#:~:text=Catecholamine%20release%20from%20nicotine%20could,fibrillation%20after%20experimental%20myocardial%20infarction. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use]=== <!--T:37--> | ||
<!--T:38--> | <!--T:38--> | ||